Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22626279 | 0.92 | CCNA2 (0.30) | — | |
| SCHEMBL17382008 | 0.92 | PDE7A (0.32) | PDE7APDE3APDE10ANR1H4 | |
| SCHEMBL16334006 | 0.92 | PDE7A (0.32) | PDE7APDE3APDE10ANR1H4 | |
| SCHEMBL29539301 | 0.92 | PDE7A (0.32) | PDE7APDE3APDE10ANR1H4 | |
| SCHEMBL29538471 | 0.92 | PDE7A (0.32) | PDE7APDE3APDE10ANR1H4 | |
| SCHEMBL16377965 | 0.90 | — | — | |
| SCHEMBL16377848 | 0.90 | CCNA2 (0.32) | PDE7APDE3APDE10A | |
| SCHEMBL29538892 | 0.90 | PDE7A (0.31) | PDE7APDE3APDE10A | |
| SCHEMBL16377735 | 0.90 | PDE7A (0.31) | PDE7APDE3APDE10A | |
| SCHEMBL16377980 | 0.89 | PDE7A (0.34) | PDE7APDE3APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10941152-B2 | Pyrazole compounds as modulators of FSHR and uses thereof | ARES TRADING S.A. (CH) | 2021-03-09 | — | — | US | disclosed |
| US-20190135823-A1 | PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF | TOCOPHERX, INC. | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190135823-A1 | PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF | FSHR, GNRHR, LHCGR | PDE7A 195/4885PDE3A 379/4885PDE10A 464/4885 |
| US-10941152-B2 | Pyrazole compounds as modulators of FSHR and uses thereof | FSHR, GNRHR, LHCGR | PDE7A 195/4885PDE3A 379/4885PDE10A 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.